Epoch Investment Partners, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Epoch Investment Partners, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q1 2014$17,855,000
-19.9%
547,860
+3.5%
0.07%
-23.4%
Q4 2013$22,295,000
+6.5%
529,190
+0.8%
0.09%
+1.1%
Q3 2013$20,927,000
-0.1%
524,745
+3.6%
0.09%
-10.6%
Q2 2013$20,938,000506,3450.10%
Other shareholders
HAEMONETICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders